Plastics in blood, placenta and brain: what detection proves

Over the past five years, researchers have reported plastic particles in human blood, in the placenta, and in brain tissue. Each finding was covered as though it were evidence of harm. It is not. Detecting a particle in a tissue establishes that the particle got there — that humans are internally exposed. Whether that exposure damages anything is a separate question these studies were not designed to answer, and mostly did not.

The distinction matters because the two claims sound alike and are not. "Microplastics are in your blood" is a statement about detection. "Microplastics in your blood are harming you" is a statement about effect. The detection studies are strong on the first and silent on the second.

Blood

A 2022 study was the first to quantify plastic particles in human blood [s1]. Working with whole blood from 22 healthy volunteers, the researchers developed a method to measure particles at or above 700 nanometres and identified four common polymers [s1]. Polyethylene terephthalate, polyethylene and styrene polymers were the most frequently found; the mean summed concentration of quantifiable particles was 1.6 micrograms per millilitre of blood [s1].

The authors' own framing was cautious. They called it a "pioneering human biomonitoring study" showing that plastic particles are "bioavailable for uptake into the human bloodstream," and stated plainly that understanding the exposure and its hazard "is needed to determine whether or not plastic particle exposure is a public health risk" [s1]. That is a research group announcing a measurement, not a diagnosis.

Placenta

A 2020 study, titled "Plasticenta," reported microplastics in human placenta for the first time [s2]. It examined six placentas from healthy pregnancies and found 12 microplastic fragments, each 5 to 10 micrometres in size, in four of them — some on the fetal side, some on the maternal side, some in the membranes [s2]. Three fragments were identified as polypropylene; the rest were identified only by their pigments, which are used in coatings, paints and cosmetics [s2].

Twelve fragments across four placentas is a small number, and the study was a detection study. It demonstrated that particles can reach the placenta. It did not measure any effect on the pregnancy, the fetus or the newborn, and did not claim to.

Brain

A 2025 study examined plastics in decedent tissue — kidney, liver and brain — using several complementary detection methods [s3]. It reported that the particles were present in all three organs and consisted mainly of polyethylene, with brain tissue carrying a higher proportion of polyethylene than liver or kidney, largely as nanoscale shard-like fragments [s3].

Two of its observations are worth stating carefully. First, the concentrations were not linked to age, sex, race or cause of death, but the year of death was: samples from 2024 carried more plastic than samples from 2016, consistent with rising environmental levels (P = 0.01) [s3]. Second, brains from decedents with a documented dementia diagnosis showed greater accumulation, with deposition in blood-vessel walls and immune cells [s3].

That second point is the one most likely to be misread. Greater plastic in dementia brains is an association measured after death, and the direction of any relationship is unknown. Dementia involves a breakdown of the blood–brain barrier and changes in how the brain clears material, which could increase deposition — meaning the disease could drive the plastic accumulation rather than the reverse. The study reports the correlation and calls for work on "routes of exposure, uptake and clearance pathways and potential health consequences" [s3]. It does not claim plastics cause dementia, and the data cannot support that claim.

What detection studies can and cannot do

These studies are genuinely informative. They establish that plastic particles cross biological barriers thought to be protective — into blood, across the placenta, into the brain [s1][s2][s3]. That is a real and non-obvious finding, and it is the necessary groundwork for any risk assessment.

What they cannot do is tell you the exposure is hurting you. None measured a health outcome as a function of particle burden. Sample sizes are small — 22 blood donors, six placentas [s1][s2]. A detection paper is also, almost by design, a first report: it announces that a method could find particles in a tissue for the first time, which is a claim about the method and the presence, not about a dose that a clinician could act on. Contamination is a constant threat, because plastic is in the air and equipment of the labs doing the measuring, which is why the field's harder problem is not finding particles but proving they were in the body rather than introduced during handling.

The reasonable reading is that human exposure is pervasive and now well documented, and that its consequences are unresolved. Both halves of that sentence are true at once, and dropping either one misrepresents where the science stands.

This article is informational and is not medical advice.

Sources

• Discovery and quantification of plastic particle pollution in human blood — Environment International, 2022-03-24
• Plasticenta: First evidence of microplastics in human placenta — Environment International, 2020-12-02
• Bioaccumulation of microplastics in decedent human brains — Nature Medicine, 2025-02-03